Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 320 entries
Sorted by: Best Match Show Resources per page
Oral Administration of Ganoderma lucidum to Lead-Exposed Rats Protects Erythrocytes against Hemolysis: Implicates to Anti-Anemia.

Evidence-based complementary and alternative medicine : eCAM

Hossain S, Bhowmick S, Islam S, Rozario L, Jahan S, Hassan M, Sarkar M, Choudhury BK, Ahmed S, Shahjalal H.
PMID: 26300947
Evid Based Complement Alternat Med. 2015;2015:463703. doi: 10.1155/2015/463703. Epub 2015 Aug 02.

We studied the effect of chronic oral exposure to lead acetate (PbA) on the sensitivity of RBC to hemolysis and whether the sensitivity could be decreased by feeding the rats with extract of medicinal mushroom Ganoderma lucidum. Three groups...

Cite
Hossain S, Bhowmick S, Islam S, et al. Oral Administration of Ganoderma lucidum to Lead-Exposed Rats Protects Erythrocytes against Hemolysis: Implicates to Anti-Anemia. Evid Based Complement Alternat Med. 2015;2015:463703doi: 10.1155/2015/463703.
Hossain, S., Bhowmick, S., Islam, S., Rozario, L., Jahan, S., Hassan, M., Sarkar, M., Choudhury, B. K., Ahmed, S., & Shahjalal, H. (2015). Oral Administration of Ganoderma lucidum to Lead-Exposed Rats Protects Erythrocytes against Hemolysis: Implicates to Anti-Anemia. Evidence-based complementary and alternative medicine : eCAM, 2015463703. https://doi.org/10.1155/2015/463703
Hossain, Shahdat, et al. "Oral Administration of Ganoderma lucidum to Lead-Exposed Rats Protects Erythrocytes against Hemolysis: Implicates to Anti-Anemia." Evidence-based complementary and alternative medicine : eCAM vol. 2015 (2015): 463703. doi: https://doi.org/10.1155/2015/463703
Hossain S, Bhowmick S, Islam S, Rozario L, Jahan S, Hassan M, Sarkar M, Choudhury BK, Ahmed S, Shahjalal H. Oral Administration of Ganoderma lucidum to Lead-Exposed Rats Protects Erythrocytes against Hemolysis: Implicates to Anti-Anemia. Evid Based Complement Alternat Med. 2015;2015:463703. doi: 10.1155/2015/463703. Epub 2015 Aug 02. PMID: 26300947; PMCID: PMC4537730.
Copy Download .nbib Format: NLM
Lung sound analysis helps localize airway inflammation in patients with bronchial asthma.

Journal of asthma and allergy

Shimoda T, Obase Y, Nagasaka Y, Nakano H, Ishimatsu A, Kishikawa R, Iwanaga T.
PMID: 28392708
J Asthma Allergy. 2017 Mar 27;10:99-108. doi: 10.2147/JAA.S125938. eCollection 2017.

No abstract available.

Cite
Shimoda T, Obase Y, Nagasaka Y, et al. Lung sound analysis helps localize airway inflammation in patients with bronchial asthma. J Asthma Allergy. 2017;10:99-108doi: 10.2147/JAA.S125938.
Shimoda, T., Obase, Y., Nagasaka, Y., Nakano, H., Ishimatsu, A., Kishikawa, R., & Iwanaga, T. (2017). Lung sound analysis helps localize airway inflammation in patients with bronchial asthma. Journal of asthma and allergy, 1099-108. https://doi.org/10.2147/JAA.S125938
Shimoda, Terufumi, et al. "Lung sound analysis helps localize airway inflammation in patients with bronchial asthma." Journal of asthma and allergy vol. 10 (2017): 99-108. doi: https://doi.org/10.2147/JAA.S125938
Shimoda T, Obase Y, Nagasaka Y, Nakano H, Ishimatsu A, Kishikawa R, Iwanaga T. Lung sound analysis helps localize airway inflammation in patients with bronchial asthma. J Asthma Allergy. 2017 Mar 27;10:99-108. doi: 10.2147/JAA.S125938. eCollection 2017. PMID: 28392708; PMCID: PMC5376185.
Copy Download .nbib Format: NLM
Precipitating factors and targeted therapies in combating the perils of sickle cell disease--- A special nutritional consideration.

Nutrition & metabolism

Khan SA, Damanhouri G, Ali A, Khan SA, Khan A, Bakillah A, Marouf S, Al Harbi G, Halawani SH, Makki A.
PMID: 27508000
Nutr Metab (Lond). 2016 Aug 08;13:50. doi: 10.1186/s12986-016-0109-7. eCollection 2016.

Nutritional research in sickle cell disease has been the focus in recent times owing to not only specific nutritional deficiencies, but also the improvements associated with less painful episodes. Though hydroxyurea remains the drug of choice, certain adverse health...

Cite
Khan SA, Damanhouri G, Ali A, et al. Precipitating factors and targeted therapies in combating the perils of sickle cell disease--- A special nutritional consideration. Nutr Metab (Lond). 2016;13:50doi: 10.1186/s12986-016-0109-7.
Khan, S. A., Damanhouri, G., Ali, A., Khan, S. A., Khan, A., Bakillah, A., Marouf, S., Al Harbi, G., Halawani, S. H., & Makki, A. (2016). Precipitating factors and targeted therapies in combating the perils of sickle cell disease--- A special nutritional consideration. Nutrition & metabolism, 1350. https://doi.org/10.1186/s12986-016-0109-7
Khan, Shahida A, et al. "Precipitating factors and targeted therapies in combating the perils of sickle cell disease--- A special nutritional consideration." Nutrition & metabolism vol. 13 (2016): 50. doi: https://doi.org/10.1186/s12986-016-0109-7
Khan SA, Damanhouri G, Ali A, Khan SA, Khan A, Bakillah A, Marouf S, Al Harbi G, Halawani SH, Makki A. Precipitating factors and targeted therapies in combating the perils of sickle cell disease--- A special nutritional consideration. Nutr Metab (Lond). 2016 Aug 08;13:50. doi: 10.1186/s12986-016-0109-7. eCollection 2016. PMID: 27508000; PMCID: PMC4977632.
Copy Download .nbib Format: NLM
Dynamic dilution exponent in monodisperse entangled polymer solutions.

Soft matter

Shahid T, Huang Q, Oosterlinck F, Clasen C, van Ruymbeke E.
PMID: 27546279
Soft Matter. 2016 Dec 21;13(1):269-282. doi: 10.1039/c6sm01083k.

We study and model the linear viscoelastic properties of several entangled semi-dilute and concentrated solutions of linear chains of different molar masses and at different concentrations dissolved in their oligomers. We discuss the dilution effect of the oligomers on...

Cite
Shahid T, Huang Q, Oosterlinck F, et al. Dynamic dilution exponent in monodisperse entangled polymer solutions. Soft Matter. 2016;13(1):269-282doi: 10.1039/c6sm01083k.
Shahid, T., Huang, Q., Oosterlinck, F., Clasen, C., & van Ruymbeke, E. (2016). Dynamic dilution exponent in monodisperse entangled polymer solutions. Soft matter, 13(1), 269-282. https://doi.org/10.1039/c6sm01083k
Shahid, T, et al. "Dynamic dilution exponent in monodisperse entangled polymer solutions." Soft matter vol. 13,1 (2016): 269-282. doi: https://doi.org/10.1039/c6sm01083k
Shahid T, Huang Q, Oosterlinck F, Clasen C, van Ruymbeke E. Dynamic dilution exponent in monodisperse entangled polymer solutions. Soft Matter. 2016 Dec 21;13(1):269-282. doi: 10.1039/c6sm01083k. PMID: 27546279.
Copy Download .nbib Format: NLM
Target Mediated Drug Disposition Model of CPHPC in Patients with Systemic Amyloidosis.

CPT: pharmacometrics & systems pharmacology

Sahota T, Berges A, Barton S, Cookson L, Zamuner S, Richards D.
PMID: 26225229
CPT Pharmacometrics Syst Pharmacol. 2015 Feb;4(2):e15. doi: 10.1002/psp4.15. Epub 2015 Feb 04.

The amyloid deposits that cause disease in systemic amyloidosis always contain the normal plasma protein, serum amyloid P (SAP) component. SAP is the target of a novel immunotherapy approach now being developed to eliminate amyloid deposits. The treatment is...

Cite
Sahota T, Berges A, Barton S, et al. Target Mediated Drug Disposition Model of CPHPC in Patients with Systemic Amyloidosis. CPT Pharmacometrics Syst Pharmacol. 2015;4(2):e15doi: 10.1002/psp4.15.
Sahota, T., Berges, A., Barton, S., Cookson, L., Zamuner, S., & Richards, D. (2015). Target Mediated Drug Disposition Model of CPHPC in Patients with Systemic Amyloidosis. CPT: pharmacometrics & systems pharmacology, 4(2), e15. https://doi.org/10.1002/psp4.15
Sahota, T, et al. "Target Mediated Drug Disposition Model of CPHPC in Patients with Systemic Amyloidosis." CPT: pharmacometrics & systems pharmacology vol. 4,2 (2015): e15. doi: https://doi.org/10.1002/psp4.15
Sahota T, Berges A, Barton S, Cookson L, Zamuner S, Richards D. Target Mediated Drug Disposition Model of CPHPC in Patients with Systemic Amyloidosis. CPT Pharmacometrics Syst Pharmacol. 2015 Feb;4(2):e15. doi: 10.1002/psp4.15. Epub 2015 Feb 04. PMID: 26225229; PMCID: PMC4360666.
Copy Download .nbib Format: NLM
Evaluation of myofibroblasts by expression of alpha smooth muscle actin: a marker in fibrosis, dysplasia and carcinoma.

Journal of clinical and diagnostic research : JCDR

Rao K B, Malathi N, Narashiman S, Rajan ST.
PMID: 24959509
J Clin Diagn Res. 2014 Apr;8(4):ZC14-7. doi: 10.7860/JCDR/2014/7820.4231. Epub 2014 Apr 15.

OBJECTIVE: Evaluation of Myofibroblasts by studying expression of Alpha smooth muscle actin: A marker of Fibrosis, Dysplasia and Carcinoma.BACKGROUND: Myofibroblasts are cells that have contractile properties and are involved in inflammation, wound healing, fibrosis and oncogenesis in most of...

Cite
Rao K B, Malathi N, Narashiman S, et al. Evaluation of myofibroblasts by expression of alpha smooth muscle actin: a marker in fibrosis, dysplasia and carcinoma. J Clin Diagn Res. 2014;8(4):ZC14-7doi: 10.7860/JCDR/2014/7820.4231.
Rao K, B., Malathi, N., Narashiman, S., & Rajan, S. T. (2014). Evaluation of myofibroblasts by expression of alpha smooth muscle actin: a marker in fibrosis, dysplasia and carcinoma. Journal of clinical and diagnostic research : JCDR, 8(4), ZC14-7. https://doi.org/10.7860/JCDR/2014/7820.4231
Rao K, Bharath, et al. "Evaluation of myofibroblasts by expression of alpha smooth muscle actin: a marker in fibrosis, dysplasia and carcinoma." Journal of clinical and diagnostic research : JCDR vol. 8,4 (2014): ZC14-7. doi: https://doi.org/10.7860/JCDR/2014/7820.4231
Rao K B, Malathi N, Narashiman S, Rajan ST. Evaluation of myofibroblasts by expression of alpha smooth muscle actin: a marker in fibrosis, dysplasia and carcinoma. J Clin Diagn Res. 2014 Apr;8(4):ZC14-7. doi: 10.7860/JCDR/2014/7820.4231. Epub 2014 Apr 15. PMID: 24959509; PMCID: PMC4064839.
Copy Download .nbib Format: NLM
Pathogenesis of bronchopulmonary dysplasia: when inflammation meets organ development.

Molecular and cellular pediatrics

Shahzad T, Radajewski S, Chao CM, Bellusci S, Ehrhardt H.
PMID: 27357257
Mol Cell Pediatr. 2016 Dec;3(1):23. doi: 10.1186/s40348-016-0051-9. Epub 2016 Jun 29.

Bronchopulmonary dysplasia is a chronic lung disease of preterm infants. It is caused by the disturbance of physiologic lung development mainly in the saccular stage with lifelong restrictions of pulmonary function and an increased risk of abnormal somatic and...

Cite
Shahzad T, Radajewski S, Chao CM, et al. Pathogenesis of bronchopulmonary dysplasia: when inflammation meets organ development. Mol Cell Pediatr. 2016;3(1):23doi: 10.1186/s40348-016-0051-9.
Shahzad, T., Radajewski, S., Chao, C. M., Bellusci, S., & Ehrhardt, H. (2016). Pathogenesis of bronchopulmonary dysplasia: when inflammation meets organ development. Molecular and cellular pediatrics, 3(1), 23. https://doi.org/10.1186/s40348-016-0051-9
Shahzad, Tayyab, et al. "Pathogenesis of bronchopulmonary dysplasia: when inflammation meets organ development." Molecular and cellular pediatrics vol. 3,1 (2016): 23. doi: https://doi.org/10.1186/s40348-016-0051-9
Shahzad T, Radajewski S, Chao CM, Bellusci S, Ehrhardt H. Pathogenesis of bronchopulmonary dysplasia: when inflammation meets organ development. Mol Cell Pediatr. 2016 Dec;3(1):23. doi: 10.1186/s40348-016-0051-9. Epub 2016 Jun 29. PMID: 27357257; PMCID: PMC4927524.
Copy Download .nbib Format: NLM
Incidence of lymph node metastasis from early gastric cancer: estimation with a large number of cases at two large centers.

Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association

Gotoda T, Yanagisawa A, Sasako M, Ono H, Nakanishi Y, Shimoda T, Kato Y.
PMID: 11984739
Gastric Cancer. 2000 Dec;3(4):219-225. doi: 10.1007/pl00011720.

BACKGROUND: The presence of lymph node metastasis (LNM) is the most important prognostic factor for patients with early gastric cancer (EGC). A D2 gastrectomy has been the gold standard treatment. Strict criteria for endoscopic mucosal resection have been widely...

Cite
Gotoda T, Yanagisawa A, Sasako M, et al. Incidence of lymph node metastasis from early gastric cancer: estimation with a large number of cases at two large centers. Gastric Cancer. 2000;3(4):219-225doi: 10.1007/pl00011720.
Gotoda, T., Yanagisawa, A., Sasako, M., Ono, H., Nakanishi, Y., Shimoda, T., & Kato, Y. (2000). Incidence of lymph node metastasis from early gastric cancer: estimation with a large number of cases at two large centers. Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 3(4), 219-225. https://doi.org/10.1007/pl00011720
Gotoda, Takuji, et al. "Incidence of lymph node metastasis from early gastric cancer: estimation with a large number of cases at two large centers." Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association vol. 3,4 (2000): 219-225. doi: https://doi.org/10.1007/pl00011720
Gotoda T, Yanagisawa A, Sasako M, Ono H, Nakanishi Y, Shimoda T, Kato Y. Incidence of lymph node metastasis from early gastric cancer: estimation with a large number of cases at two large centers. Gastric Cancer. 2000 Dec;3(4):219-225. doi: 10.1007/pl00011720. PMID: 11984739.
Copy Download .nbib Format: NLM
Limited proteolysis of NACP/alpha-synuclein.

Journal of Alzheimer's disease : JAD

Hossain S, Alim A, Takeda K, Kaji H, Shinoda T, Uéda K.
PMID: 12214024
J Alzheimers Dis. 2001 Dec;3(6):577-584. doi: 10.3233/jad-2001-3608.

The NAC region of NACP/alpha-synuclein is a secondary component of Alzheimer's disease amyloid. alpha-Synuclein is a major component of Lewy bodies, a typical neuropathological feature of Parkinson's disease. However, the physiological role and deposition mechanisms of alpha-synuclein are unknown....

Cite
Hossain S, Alim A, Takeda K, et al. Limited proteolysis of NACP/alpha-synuclein. J Alzheimers Dis. 2001;3(6):577-584doi: 10.3233/jad-2001-3608.
Hossain, S., Alim, A., Takeda, K., Kaji, H., Shinoda, T., & Uéda, K. (2001). Limited proteolysis of NACP/alpha-synuclein. Journal of Alzheimer's disease : JAD, 3(6), 577-584. https://doi.org/10.3233/jad-2001-3608
Hossain, Shahanara, et al. "Limited proteolysis of NACP/alpha-synuclein." Journal of Alzheimer's disease : JAD vol. 3,6 (2001): 577-584. doi: https://doi.org/10.3233/jad-2001-3608
Hossain S, Alim A, Takeda K, Kaji H, Shinoda T, Uéda K. Limited proteolysis of NACP/alpha-synuclein. J Alzheimers Dis. 2001 Dec;3(6):577-584. doi: 10.3233/jad-2001-3608. PMID: 12214024.
Copy Download .nbib Format: NLM
A mild photoactivated hydrophilic/hydrophobic switch.

Langmuir : the ACS journal of surfaces and colloids

Critchley K, Jeyadevan JP, Fukushima H, Ishida M, Shimoda T, Bushby RJ, Evans SD.
PMID: 16032872
Langmuir. 2005 May 10;21(10):4554-61. doi: 10.1021/la046851s.

Surface modification using light is one of the most powerful methods for controlling the physical and chemical properties offunctionalized surfaces. In this paper, we report on systems where soft UV irradiation (lambda = 365 nm) converts a "low" activity...

Cite
Critchley K, Jeyadevan JP, Fukushima H, et al. A mild photoactivated hydrophilic/hydrophobic switch. Langmuir. 2005;21(10):4554-61doi: 10.1021/la046851s.
Critchley, K., Jeyadevan, J. P., Fukushima, H., Ishida, M., Shimoda, T., Bushby, R. J., & Evans, S. D. (2005). A mild photoactivated hydrophilic/hydrophobic switch. Langmuir : the ACS journal of surfaces and colloids, 21(10), 4554-61. https://doi.org/10.1021/la046851s
Critchley, Kevin, et al. "A mild photoactivated hydrophilic/hydrophobic switch." Langmuir : the ACS journal of surfaces and colloids vol. 21,10 (2005): 4554-61. doi: https://doi.org/10.1021/la046851s
Critchley K, Jeyadevan JP, Fukushima H, Ishida M, Shimoda T, Bushby RJ, Evans SD. A mild photoactivated hydrophilic/hydrophobic switch. Langmuir. 2005 May 10;21(10):4554-61. doi: 10.1021/la046851s. PMID: 16032872.
Copy Download .nbib Format: NLM
Spectral parameters and Hamaker constants of silicon hydride compounds and organic solvents.

Journal of colloid and interface science

Masuda T, Matsuki Y, Shimoda T.
PMID: 19781714
J Colloid Interface Sci. 2009 Dec 15;340(2):298-305. doi: 10.1016/j.jcis.2009.08.028. Epub 2009 Aug 21.

Cyclopentasilane (CPS) and polydihydrosilane, which consist of hydrogen and silicon only, are unique materials that can be used to produce intrinsic silicon film in a liquid process, such as spin coating or an ink-jet method. Wettability and solubility of...

Cite
Masuda T, Matsuki Y, Shimoda T. Spectral parameters and Hamaker constants of silicon hydride compounds and organic solvents. J Colloid Interface Sci. 2009;340(2):298-305doi: 10.1016/j.jcis.2009.08.028.
Masuda, T., Matsuki, Y., & Shimoda, T. (2009). Spectral parameters and Hamaker constants of silicon hydride compounds and organic solvents. Journal of colloid and interface science, 340(2), 298-305. https://doi.org/10.1016/j.jcis.2009.08.028
Masuda, Takashi, et al. "Spectral parameters and Hamaker constants of silicon hydride compounds and organic solvents." Journal of colloid and interface science vol. 340,2 (2009): 298-305. doi: https://doi.org/10.1016/j.jcis.2009.08.028
Masuda T, Matsuki Y, Shimoda T. Spectral parameters and Hamaker constants of silicon hydride compounds and organic solvents. J Colloid Interface Sci. 2009 Dec 15;340(2):298-305. doi: 10.1016/j.jcis.2009.08.028. Epub 2009 Aug 21. PMID: 19781714.
Copy Download .nbib Format: NLM
Effects of CYP2B6 G516T polymorphisms on plasma efavirenz and nevirapine levels when co-administered with rifampicin in HIV/TB co-infected Thai adults.

AIDS research and therapy

Uttayamakul S, Likanonsakul S, Manosuthi W, Wichukchinda N, Kalambaheti T, Nakayama EE, Shioda T, Khusmith S.
PMID: 20338069
AIDS Res Ther. 2010 Mar 26;7:8. doi: 10.1186/1742-6405-7-8.

BACKGROUND: Cytochrome P450 2B6 (CYP2B6) metabolizes efavirenz and nevirapine, the major core antiretroviral drugs for HIV in Thailand. Rifampicin, a critical component of tuberculosis (TB) therapy is a potent inducer of CYP enzyme activity. Polymorphisms of CYP2B6 and CYP3A4...

Cite
Uttayamakul S, Likanonsakul S, Manosuthi W, et al. Effects of CYP2B6 G516T polymorphisms on plasma efavirenz and nevirapine levels when co-administered with rifampicin in HIV/TB co-infected Thai adults. AIDS Res Ther. 2010;7:8doi: 10.1186/1742-6405-7-8.
Uttayamakul, S., Likanonsakul, S., Manosuthi, W., Wichukchinda, N., Kalambaheti, T., Nakayama, E. E., Shioda, T., & Khusmith, S. (2010). Effects of CYP2B6 G516T polymorphisms on plasma efavirenz and nevirapine levels when co-administered with rifampicin in HIV/TB co-infected Thai adults. AIDS research and therapy, 78. https://doi.org/10.1186/1742-6405-7-8
Uttayamakul, Sumonmal, et al. "Effects of CYP2B6 G516T polymorphisms on plasma efavirenz and nevirapine levels when co-administered with rifampicin in HIV/TB co-infected Thai adults." AIDS research and therapy vol. 7 (2010): 8. doi: https://doi.org/10.1186/1742-6405-7-8
Uttayamakul S, Likanonsakul S, Manosuthi W, Wichukchinda N, Kalambaheti T, Nakayama EE, Shioda T, Khusmith S. Effects of CYP2B6 G516T polymorphisms on plasma efavirenz and nevirapine levels when co-administered with rifampicin in HIV/TB co-infected Thai adults. AIDS Res Ther. 2010 Mar 26;7:8. doi: 10.1186/1742-6405-7-8. PMID: 20338069; PMCID: PMC2859392.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 320 entries